Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03620643
Title Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours (ROLo)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Indications

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

diffuse gastric cancer

Advanced Solid Tumor

Therapies

Crizotinib

Crizotinib + Fulvestrant

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Beatson West of Scotland Cancer Centre Recruiting Glasgow United Kingdom Details
St Luke's Cancer Centre Not yet recruiting Guildford United Kingdom Details
Clatterbridge Cancer Centre Not yet recruiting Liverpool United Kingdom Details
Royal Marsden NHS Foundation Trust Recruiting London SW3 6JJ United Kingdom Details
Guys and St Thomas NHS Foundation Trust Recruiting London United Kingdom Details
University College London Hospital Recruiting London United Kingdom Details
The Christie NHS Foundation Trust Recruiting Manchester United Kingdom Details
Weston Park Cancer Centre Not yet recruiting Sheffield United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field